4H045 ペプチド又は蛋白質技術 Patent Trends
The Theme Code "ペプチド又は蛋白質技術" had 2,194 patent application filings in the publication-lag-adjusted comparison period (2024-01-01 to 2024-10-31). This is a with an decreasing trend transition of -475 filings (-17.8%) over 2,669 they had in the same period of the previous year (2023-01-01 to 2023-10-31).
The highest number of filings in 2021 with 4,560 cases, and their lowest number in 2024 with 2,263 cases (years covered: 2021, 2022, 2023, 2024).
The mean of the number of filings over the last 4 years (2021 to 2024, 13,889 cases in total) is 3,472, and the median is 3,533. The coefficient of variation (standard deviation/mean) is 0.24, and filings have been moderate fluctuations.
| Index | Value |
|---|---|
| Average | 3,472 patents |
| Std Dev | 833 |
| COV | 0.24 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 171 cases | -92.4% |
| 2024 year | 2,263 cases | -31.0% |
| 2023 year | 3,282 cases | -13.27% |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ペプチド又は蛋白質技術[4H045] for the period of the last 6 years (2020 to 2025). You can compare the information in this report with the trends in your competitors’ patent filings and technologies.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ペプチド又は蛋白質技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, and their top coapplicants (joint research partners, alliance partners). It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
ペプチド又は蛋白質技術, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of ペプチド又は蛋白質技術 over the last 6 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
ペプチド又は蛋白質技術 JP patent filing trend (unit: cases)
| Year | Cases |
|---|---|
| 2021 | 4,560 |
| 2022 | 3,784 |
| 2023 | 3,282 |
| 2024 | 2,263 |
| 2025 | 171 |
Patent Landscape
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for ペプチド又は蛋白質技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
Keywords (importance)
Top keywords frequently used in patent filings for ペプチド又は蛋白質技術 are shown below.
Top keywords for ペプチド又は蛋白質技術
| Keyword | Score |
|---|---|
| 結合 | 100.0 |
| 抗体 | 98.27 |
| 組成 | 95.35 |
| 細胞 | 80.61 |
| 疾患 | 60.05 |
| 活性 | 56.39 |
| 配列 | 54.73 |
| 治療 | 51.67 |
| タンパク質 | 45.23 |
| 特異 | 41.87 |
| 修正 | 41.14 |
| 癌 | 36.78 |
| ヒト | 34.14 |
| 予防 | 31.41 |
| 発現 | 30.43 |
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 14,060 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
ペプチド又は蛋白質技術[4H045]
Recent publications
| Publication No. | Title | Bibliographic info | Theme |
|---|---|---|---|
| 1. JPA2026-154940 | インターロイキン１アルファに特異的な真のヒト抗体 | ・Applicant エックスバイオテクインコーポレイテッド ・Filing date 2021-10-04 ・Publication date 2026-10-05 | 4H045 |
| 2. JPA-HYO2026-533127 | グリピカン－３発現腫瘍の治療に使用するためのポリペプチド | ・Applicant サノフイ ・Filing date 2024-09-04 ・Publication date 2026-10-05 | 4H045 |
| 3. JPA-HYO2026-533136 | フィラデルフィア染色体陽性血液がんの治療における使用のためのＳＯＳ１阻害剤 | ・Applicant カムクワットバイオサイエンシーズインコーポレイテッド ・Filing date 2024-09-10 ・Publication date 2026-10-05 | 4H045 |
| 4. JPA-HYO2026-533173 | 糖鎖工学用細胞および使用方法 | ・Applicant ロック・バイオメディカル・インコーポレイテッド ・Filing date 2024-06-19 ・Publication date 2026-10-05 | 4B064, 4B065, 4H045 |
| 5. JPA-HYO2026-533238 | 熱安定性コクサッキーウイルスＡ群６型株及びその使用 | ・Applicant 武漢生物制品研究所有限責任公司 ・Filing date 2024-09-25 ・Publication date 2026-10-05 | 4B065, 4H045 |
| 6. JPA-HYO2026-533277 | 組換えＣ型肝炎ウイルス糖タンパク質、その組成物、及びその用途 | ・Applicant スティフティングアムステルダムユーエムセー ・Filing date 2024-10-01 ・Publication date 2026-10-05 | 4B065, 4H045 |
| 7. JPP7929511 | ＳＨ３ＹＬ１抗体、それを含む組成物、ならびにそのベクターおよび使用 | ・Applicant セルロスバイオテック ・Filing date 2021-09-14 ・Publication date 2026-10-05 | 4B064, 4B065, 4C084, 4C085, 4C087, +1 more |
| 8. JPP7929878 | 二重特異性抗体及びその使用 | ・Applicant 康諾亜生物医薬科技有限公司 ・Filing date 2021-11-22 ・Publication date 2026-10-05 | 4B065, 4H045 |
| 9. JPA2026-154956 | １９１Ｐ４Ｄ１２タンパク質に結合する抗体薬物複合体（ＡＤＣ）を用いたがんの治療方法 | ・Applicant アジェンシスインコーポレイテッド, シージェンインコーポレイテッド ・Filing date 2021-09-16 ・Publication date 2026-10-05 | 4C076, 4H045 |
| 10. JPA2026-154979 | ＦＬＲＴ３媒介性シグナル伝達を調節するための組成物及び方法 | ・Applicant ネクストキュアインコーポレイテッド ・Filing date 2021-06-21 ・Publication date 2026-10-05 | 4H045 |
| 11. JPA-HYO2026-533141 | ＭＡＮＰの製剤およびその使用 | ・Applicant イー-スター、バイオテック、リミテッド、ライアビリティー、カンパニー ・Filing date 2024-09-04 ・Publication date 2026-10-05 | 4C047, 4C066, 4C076, 4H045 |
| 12. JPA-HYO2026-533157 | 高粘度限外濾過／ダイアフィルトレーションおよびシングルパスタンジェンシャルフロー濾過プロセス | ・Applicant ジェネンテックインコーポレイテッド ・Filing date 2024-09-06 ・Publication date 2026-10-05 | 4H045 |
| 13. JPA-HYO2026-533231 | 感染症の予防及び／又は治療のための組成物及びその使用 | ・Applicant アストリッドファーマコーポレイション ・Filing date 2024-09-20 ・Publication date 2026-10-05 | 4H045 |
| 14. JPA2026-154927 | アレルギーおよび炎症状態を治療するための組成物および方法 | ・Applicant ユニバーシティオブピッツバーグ-オブザコモンウェルスシステムオブハイヤーエデュケイション ・Filing date 2022-05-06 ・Publication date 2026-10-05 | 4C076, 4C267, 4H045 |
| 15. JPA2026-154965 | ターゲティングされた触媒性補体活性化分子およびその使用方法 | ・Applicant オメロスコーポレーション ・Filing date 2022-10-06 ・Publication date 2026-10-05 | 4B064, 4B065, 4C076, 4H045 |
Same industry / competition company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 103 cases, followed by イーライリリーアンドカンパニー with 60 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 103 cases |
| イーライリリーアンドカンパニー | 60 cases |
| ジェネンテックインコーポレイテッド | 52 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 46 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 34 cases |
| ヤンセンバイオテツクインコーポレーテツド | 31 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 366 cases, followed by ジェネンテックインコーポレイテッド with 212 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 366 cases |
| ジェネンテックインコーポレイテッド | 212 cases |
| ヤンセンバイオテツクインコーポレーテツド | 202 cases |
| イーライリリーアンドカンパニー | 169 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 142 cases |
Same industry / competition company JP patent filing ranking
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 6 companies in the same industry over the past 6 years.
Competitor filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 366 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 202 |
| イーライリリーアンドカンパニー | 169 |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 142 |
Top company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 103 cases, followed by イーライリリーアンドカンパニー with 60 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 103 cases |
| イーライリリーアンドカンパニー | 60 cases |
| ジェネンテックインコーポレイテッド | 52 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 366 cases, followed by ジェネンテックインコーポレイテッド with 212 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 366 cases |
| ジェネンテックインコーポレイテッド | 212 cases |
| イーライリリーアンドカンパニー | 169 cases |
Top company JP patent filing ranking
Below is a ranking of the number of JP patent applications by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 366 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 202 |
Top company, Change in the Number of JP Patents
Below is a patent map showing the changes in the numbers of JP patent filings by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 366 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 202 |
Top company details
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
ペプチド又は蛋白質技術 filed 366 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 366 cases in total) is 73.2, and the median is 63.0. The coefficient of variation (standard deviation/mean) is 0.5, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 142 cases, and their lowest number in 2024 with 40 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 73.2 patents |
| Std Dev | 35.5 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 40 cases | -36.5% |
| 2023 year | 63 cases | +12.50% |
Trends in filing of joint patent applications with イーライリリーアンドカンパニー
ペプチド又は蛋白質技術 filed 169 joint applications with イーライリリーアンドカンパニー for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 161 cases in total) is 32.2, and the median is 33.0. The coefficient of variation (standard deviation/mean) is 0.21, and filings have been moderate fluctuations.
The highest number of filings in 2022 with 39 cases, and their lowest number in 2024 with 20 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 32.2 patents |
| Std Dev | 6.6 |
| COV | 0.21 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 8 cases | -60.0% |
| 2024 year | 20 cases | -37.5% |
| 2023 year | 32 cases | -17.95% |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
ペプチド又は蛋白質技術 filed 212 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 209 cases in total) is 41.8, and the median is 45.0. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
The highest number of filings in 2021 with 65 cases, and their lowest number in 2024 with 18 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 41.8 patents |
| Std Dev | 16.1 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 3 cases | -83.3% |
| 2024 year | 18 cases | -41.9% |
| 2023 year | 31 cases | -31.1% |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む